Edwards Lifesciences Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

EW Stock Price Prediction

AI-generated analysis

🎯 24/7 Wall St. sets a 12-month price target of $111.36 for Edwards Lifesciences Corp (EW), implying a 17.45% upside from the current price of $94.82.

πŸ“Š Wall Street sentiment is predominantly positive with 21 Buy ratings and 8 Hold ratings among 29 analysts covering the stock.

πŸš€ The optimistic scenario projects EW reaching $127.71 over the next year, representing a potential 34.7% gain from current levels.

πŸ›‘οΈ The conservative scenario establishes a price floor at $97.47, indicating limited downside risk and a roughly flat outlook for the stock.

πŸ“ˆ Long-term forecasts through 2030 project an average trading price of $142.24 with a potential range between $106.68 and $177.80.

πŸ’‘ The analysis incorporates analyst consensus, valuation metrics, technical indicators, and market sentiment into its proprietary pricing model.

Bullish Signals
  • The stock is rated as a BUY by 24/7 Wall St. with a strong upside potential of 17.4% to the target price.
  • Wall Street analyst consensus shows a 72% buy rating, indicating broad institutional confidence in the company's prospects.
  • The conservative scenario suggests limited downside risk, projecting the stock to remain flat or slightly higher than current levels.
  • Long-term projections indicate a potential 50.0% return from today's price by 2030 if execution and market conditions align favorably.
Full Analysis
24/7 Wall St. has issued a price target of $111.36 for Edwards Lifesciences Corp (EW) over the next 12 months, implying a 17.45% upside from the current trading price of $94.82. The analysis categorizes the stock as attractively valued with a favorable risk-reward profile for investors holding a one-year horizon. Wall Street consensus remains bullish, with 21 out of 29 analysts rating EW as a Buy and 8 as Hold, resulting in a 72% buy rating. The proprietary model projects an optimistic scenario where the stock could reach $127.71, representing a 34.7% gain, assuming strong earnings growth and successful execution of company initiatives. Conversely, the conservative scenario places the price floor at $97.47, suggesting limited downside risk as the stock trades roughly flat or slightly higher than current levels even under adverse conditions. Long-term projections through 2030 estimate an average price of $142.24, contingent on company execution and broader market dynamics. The article concludes with standard disclaimers noting that these forecasts are forward-looking estimates incorporating analyst consensus and valuation metrics rather than guarantees. Actual performance may vary due to earnings surprises, macroeconomic changes, and market psychology.